1. MARKETS
  2. SECTOR : HEALTHCARE EQUIPMENT & SUPPLIES
  3. INDUSTRY : MEDICAL SPECIALTIES
  4. BETTER THERAPEUTICS INC

Better Therapeutics Inc

XNAS: BTTX

Watchlist

Portfolio

Share
Board Meeting
The next board meeting for Better Therapeutics Inc is on 26 Mar 2025 for the purpose of Better Therapeutics Inc Fourth Quarter Earnings Conference Call for 2024 See details


Insider Trading disclosures for Better Therapeutics Inc

The latest disclosure was made by Perry David in Better Therapeutics Inc where a trade of 839,895 Common Stock done at an average price of $0.2 was reported to US exchanges on Feb. 9, 2024.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Perry David Director, Executive Chairman, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.19 per share. 09 Feb 2024 839,895 2,416,634 - 0.2 160,000 Common Stock
David Perry Director, Executive Chairman, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.17 per share. 09 Jan 2024 1,471,453 1,576,739 - 0.2 250,000 Common Stock
Geoffrey M. Parker Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Dec 2023 3,750 1,031,805 - 0 Common Stock
Frank Karbe L. Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Dec 2023 62,500 526,516 - 0 Common Stock
David Perry Director, Executive Chairman, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Dec 2023 3,750 105,286 - 0 Common Stock
Granger Elder Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Dec 2023 3,750 39,601 - 0 Common Stock
Kristin Wynholds Chief Product Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Dec 2023 25,362 225,631 - 0 Common Stock
Miller Leslie Principal Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Dec 2023 3,587 17,937 - 0 Common Stock
Carmona H. Richard Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Dec 2023 3,750 157,369 - 0 Common Stock
Berman Mark Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Dec 2023 25,362 448,140 - 0 Common Stock
Frank L. Karbe Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 0.73 per share. 27 Jul 2023 137,005 429,429 - 0.7 100,000 Common Stock
Geoffrey M. Parker Director Purchase of securities on an exchange or from another person at price $ 0.73 per share. 27 Jul 2023 685,025 1,028,055 - 0.7 500,000 Common Stock
David Perry Director, Executive Chairman, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.73 per share. 27 Jul 2023 1,233,045 13,030,393 - 0.7 900,000 Common Stock
Elder Granger Director Purchase of securities on an exchange or from another person at price $ 0.73 per share. 27 Jul 2023 34,251 35,851 - 0.7 25,000 Common Stock
Mark Berman Chief Medical Officer Purchase of securities on an exchange or from another person at price $ 0.73 per share. 27 Jul 2023 54,802 388,191 - 0.7 40,000 Common Stock
Richard H. Carmona Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2023 15,000 15,000 - - Stock Option (Right to Buy)
Geoffrey M. Parker Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2023 15,000 15,000 - - Stock Option (Right to Buy)
David Perry Director, Executive Chairman, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2023 15,000 15,000 - - Stock Option (Right to Buy)
Elder Granger Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2023 15,000 15,000 - - Stock Option (Right to Buy)
Elder Granger Director Purchase of securities on an exchange or from another person at price $ 0.87 per share. 16 May 2023 600 1,600 - 0.9 520 Common Stock
Geoffrey M. Parker Director Purchase of securities on an exchange or from another person at price $ 0.83 per share. 10 Apr 2023 303,030 343,030 - 0.8 250,000 Common Stock
David Perry Director, See Remarks, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.83 per share. 10 Apr 2023 1,333,333 11,797,348 - 0.8 1,100,000 Common Stock
David Perry Director, See Remarks, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.82 per share. 10 Apr 2023 3,636,364 3,636,364 - 0.8 3,000,000 Common Stock
Frank L. Karbe Director, See Remarks Purchase of securities on an exchange or from another person at price $ 0.83 per share. 10 Apr 2023 242,424 292,424 - 0.8 200,000 Common Stock
Mark Berman Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2023 101,450 101,450 - - Stock Option (Right to Buy)
Mark Berman Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2023 101,450 333,389 - 0 Common Stock
Kristin Wynholds Chief Product Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2023 101,450 101,450 - - Stock Option (Right to Buy)
Kristin Wynholds Chief Product Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2023 101,450 200,269 - 0 Common Stock
Mark Heinen Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2023 28,550 28,550 - - Stock Option (Right to Buy)
Mark Heinen Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2023 54,000 139,723 - 0 Common Stock
Mark Heinen See Remarks Grant, award, or other acquisition of securities at price $ 1.24 per share. 30 Nov 2022 15,723 85,723 - 1.2 19,512 Common Stock
Frank L. Karbe Director, See Remarks Purchase of securities on an exchange or from another person at price $ 2.09 per share. 15 Sep 2022 50,000 50,000 - 2.1 104,695 Common Stock
David Perry Director, See Remarks, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 2.07 per share. 15 Sep 2022 39,156 101,536 - 2.1 80,975 Common Stock
David Perry Director, See Remarks, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 1.99 per share. 15 Sep 2022 10,844 62,380 - 2.0 21,623 Common Stock
Mark Heinen See Remarks Purchase of securities on an exchange or from another person at price $ 1.94 per share. 12 Sep 2022 26,132 70,000 - 1.9 50,696 Common Stock
Mark Heinen See Remarks Purchase of securities on an exchange or from another person at price $ 1.94 per share. 12 Sep 2022 23,868 43,868 - 1.9 46,304 Common Stock
Frank L. Karbe Director, See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jul 2022 472,200 472,200 - - Stock Option (Right to Buy)
Mark Heinen See Remarks Purchase of securities on an exchange or from another person at price $ 1.75 per share. 24 Jun 2022 2,280 2,280 - 1.8 4,000 Common Stock
Geoffrey M. Parker Director Purchase of securities on an exchange or from another person at price $ 1.45 per share. 13 Jun 2022 25,000 40,000 - 1.4 36,183 Common Stock
Mark Heinen See Remarks Purchase of securities on an exchange or from another person at price $ 1.56 per share. 10 Jun 2022 5,000 20,000 - 1.6 7,800 Common Stock
David Perry Director, See Remarks, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2022 15,000 15,000 - - Stock Option (Right to Buy)
Suying Liu Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2022 15,000 15,000 - - Stock Option (Right to Buy)
Elder Granger Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2022 15,000 15,000 - - Stock Option (Right to Buy)
Richard H. Carmona Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2022 15,000 15,000 - - Stock Option (Right to Buy)
Geoffrey M. Parker Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2022 15,000 15,000 - - Stock Option (Right to Buy)
Kristin Wynholds Chief Product Officer Grant, award, or other acquisition of securities at price $ 1.24 per share. 31 May 2022 3,781 98,819 - 1.2 4,692 Common Stock
Kristin Wynholds Chief Product Officer Grant, award, or other acquisition of securities at price $ 1.54 per share. 31 May 2022 5,023 95,038 - 1.5 7,728 Common Stock
Justin Zamirowski Chief Commercial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.50 per share. 27 May 2022 1,677 36,913 - 0.5 839 Common Stock
Justin Zamirowski Chief Commercial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 May 2022 1,677 43,626 - - Stock Option (Right to Buy)
Justin Zamirowski Chief Commercial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.50 per share. 16 May 2022 35,236 35,236 - 0.5 17,618 Common Stock
Justin Zamirowski Chief Commercial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 May 2022 35,236 45,303 - - Stock Option (Right to Buy)
Justin Zamirowski Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Apr 2022 86,800 86,800 - - Stock Option (Right to Buy)
Mark Berman Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Apr 2022 116,700 116,700 - - Stock Option (Right to Buy)
Kristin Wynholds Chief Product Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Apr 2022 116,700 116,700 - - Stock Option (Right to Buy)
Kevin Appelbaum Director, Chief Executive Officer, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2022 235,000 235,000 - - Stock Option (Right to Buy)
Kevin Appelbaum Director, Chief Executive Officer, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 1.97 per share. 31 Mar 2022 2,500 6,250 - 2.0 4,921 Common Stock
Mark Heinen See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2022 32,800 32,800 - - Stock Option (Right to Buy)
Mark Heinen See Remarks Purchase of securities on an exchange or from another person at price $ 1.98 per share. 31 Mar 2022 5,000 15,000 - 2.0 9,900 Common Stock
Geoffrey M. Parker Director Purchase of securities on an exchange or from another person at price $ 2.15 per share. 29 Mar 2022 15,000 15,000 - 2.1 32,231 Common Stock
Kevin Appelbaum Director, Chief Executive Officer, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 4.60 per share. 20 Dec 2021 1,000 3,750 - 4.6 4,600 Common Stock
Geoffrey M. Parker Director Purchase of securities on an exchange or from another person at price $ 4.94 per share. 14 Dec 2021 20,000 53,333 - 4.9 98,800 Common Stock
Mark Heinen See Remarks Purchase of securities on an exchange or from another person at price $ 4.69 per share. 13 Dec 2021 2,333 10,000 - 4.7 10,953 Common Stock
Mark Heinen See Remarks Purchase of securities on an exchange or from another person at price $ 5.44 per share. 13 Dec 2021 500 7,667 - 5.4 2,721 Common Stock
Mark Heinen See Remarks Purchase of securities on an exchange or from another person at price $ 5.45 per share. 13 Dec 2021 500 7,167 - 5.5 2,725 Common Stock
Kevin Appelbaum Director, Chief Executive Officer, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 5.98 per share. 10 Dec 2021 1,000 2,000 - 6.0 5,975 Common Stock
Kevin Appelbaum Director, Chief Executive Officer, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 6.43 per share. 02 Dec 2021 500 1,000 - 6.4 3,213 Common Stock
Kevin Appelbaum Director, Chief Executive Officer, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 6.84 per share. 02 Dec 2021 500 500 - 6.8 3,420 Common Stock
Elder Granger Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Nov 2021 28,300 28,300 - - Stock Option (Right to Buy)
Richard H. Carmona Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Oct 2021 153,619 153,619 - - Common Stock
Geoffrey M. Parker Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Oct 2021 33,333 33,333 - - Common Stock
Suying Liu Director Other type of transaction at price $ 0.00 per share. 28 Oct 2021 1,388,250 0 - - Common Stock
Suying Liu Director Other type of transaction at price $ 0.00 per share. 28 Oct 2021 14,250 1,388,250 - - Common Stock
Suying Liu Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Oct 2021 28,300 28,300 - - Stock Option (Right to Buy)
Suying Liu Director Other type of transaction at price $ 0.00 per share. 28 Oct 2021 142,500 0 - - Rights
Mark Heinen See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Oct 2021 51,920 51,920 - - Stock Option (Right to Buy)
Mark Heinen See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Oct 2021 6,667 33,333 - - Common Stock
Geoffrey M. Parker Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Oct 2021 28,300 28,300 - - Stock Option (Right to Buy)
Richard H. Carmona Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Oct 2021 28,300 28,300 - - Stock Option (Right to Buy)
David Perry Director, See Remarks, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Apr 2021 21,336 10,530,037 - - Common Stock
David Perry Director, See Remarks, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Apr 2021 293,150 10,508,701 - - Common Stock
David Perry Director, See Remarks, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 10.00 per share. 30 Apr 2021 200,000 10,730,037 - 10 2,000,000 Common Stock
David Perry Director, See Remarks, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 9.94 per share. 30 Apr 2021 8,000 31,536 - 9.9 79,520 Common Stock
David Perry Director, See Remarks, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 9.95 per share. 30 Apr 2021 8,000 23,536 - 10.0 79,600 Common Stock
David Perry Director, See Remarks, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 9.93 per share. 30 Apr 2021 3,060 15,536 - 9.9 30,386 Common Stock
David Perry Director, See Remarks, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 9.93 per share. 30 Apr 2021 7,000 12,476 - 9.9 69,510 Common Stock
David Perry Director, See Remarks, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 9.93 per share. 30 Apr 2021 3,476 5,476 - 9.9 34,517 Common Stock
David Perry Director, See Remarks, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 9.95 per share. 30 Apr 2021 2,000 2,000 - 10.0 19,900 Common Stock
David Perry Director, See Remarks, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 10.00 per share. 30 Apr 2021 100,000 10,830,037 - 10 1,000,000 Common Stock
David Perry Director, See Remarks, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Apr 2021 28,300 28,300 - - Stock Option (Right to Buy)
David Perry Director, See Remarks, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Apr 2021 10,164,015 10,215,551 - - Common Stock
David Perry Director, See Remarks, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 9.95 per share. 30 Apr 2021 20,000 51,536 - 10.0 199,000 Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters